Vortioxetine 10 mg
201509107
Approved small_molecule completed
Quick answer
Vortioxetine 10 mg for Age-related Cognitive Decline is a Approved program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Age-related Cognitive Decline
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed